Log in to save to my catalogue

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angio...

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7341764dc8e949829a64d14fa44fbf34

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy

About this item

Full title

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy

Publisher

England: BioMed Central Ltd

Journal title

Molecular neurodegeneration, 2023-03, Vol.18 (1), p.17-17, Article 17

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Alzheimer Disease (AD) and cerebral amyloid angiopathy (CAA) are both characterized by amyloid-β (Aβ) accumulation in the brain, although Aβ deposits mostly in the brain parenchyma in AD and in the cerebrovasculature in CAA. The presence of CAA can exacerbate clinical outcomes of AD patients by promoting spontaneous intracerebral hemorrhage and isc...

Alternative Titles

Full title

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7341764dc8e949829a64d14fa44fbf34

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7341764dc8e949829a64d14fa44fbf34

Other Identifiers

ISSN

1750-1326

E-ISSN

1750-1326

DOI

10.1186/s13024-023-00610-x

How to access this item